Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

OXCARBAZEPINE

FDA · NDA · 2025-09-23

AgencyFDA
Submission typeNDA
Action date2025-09-23
BrandTRILEPTAL
SponsorNOVARTIS
RouteORAL

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:35:40.219Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:OXCARBAZEPINE:2025-09-23

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

OXCARBAZEPINE — approval | AEaH